Topics

FDA Grants Limited Approval of Sanofi Pasteur’s Dengue Vaccine in Children

14:39 EDT 2 May 2019 | Speciality Pharma Journal

The U.S. Food and Drug Administration announced today the approval of Dengvaxia, the first vaccine approved for the prevention of dengue disease caused by all dengue virus serotypes (1, 2, 3 and 4) in people ages 9 through 16 who have laboratory-confirmed previous dengue infection and who live in endemic areas. Dengue is endemic in …

Original Article: FDA Grants Limited Approval of Sanofi Pasteur’s Dengue Vaccine in Children

NEXT ARTICLE

More From BioPortfolio on "FDA Grants Limited Approval of Sanofi Pasteur’s Dengue Vaccine in Children"

Quick Search

Relevant Topics

Vaccines
A vaccine is any preparation intended to produce immunity to a disease by stimulating the production of antibodies. It creates immunity but does not cause the disease. There are several differnt types of vaccine avalable; Killed microorganisms; which s...

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...